UA100785U - Method for assessment of azilsartan efficacy in treatment of patients with ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of the ventricle according to "hypertrophic" type - Google Patents

Method for assessment of azilsartan efficacy in treatment of patients with ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of the ventricle according to "hypertrophic" type

Info

Publication number
UA100785U
UA100785U UAU201501599U UAU201501599U UA100785U UA 100785 U UA100785 U UA 100785U UA U201501599 U UAU201501599 U UA U201501599U UA U201501599 U UAU201501599 U UA U201501599U UA 100785 U UA100785 U UA 100785U
Authority
UA
Ukraine
Prior art keywords
treatment
azilsartan
patients
hypertrophic
impairment
Prior art date
Application number
UAU201501599U
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Каріна Миколаївна Кишко
Михайло Михайлович Черняк
Тетяна Василівна Кишко
Тетяна Василівна Мишанич
Микола Максимович Кишко
Михайло Васильович Бичко
Original Assignee
Державний Вищий Навчальний Заклад "Ужгородський Національний Університет"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Державний Вищий Навчальний Заклад "Ужгородський Національний Університет" filed Critical Державний Вищий Навчальний Заклад "Ужгородський Національний Університет"
Priority to UAU201501599U priority Critical patent/UA100785U/en
Publication of UA100785U publication Critical patent/UA100785U/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The method for the assessment of Azilsartan efficacy in the treatment of the patients with the ischemic heart disease with angina pectoris and the arterial hypertension with the impairment of diastolic function of the left ventricle according to "hypertrophic" type comprises the comparison of the state of the patients prior to and after the treatment. Prior to the treatment, Doppler echocardiography at rest is performed and transmitral blood flow is assessed by measuring the rate of early diastolic filling. The same examination is provided after treatment with Azilsartan. When the rate of early diastolic filling increases by at least 9.3 % as compared with that prior to the treatment, the hemodynamic result and antianginal effect are considered as positive.
UAU201501599U 2015-02-24 2015-02-24 Method for assessment of azilsartan efficacy in treatment of patients with ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of the ventricle according to "hypertrophic" type UA100785U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201501599U UA100785U (en) 2015-02-24 2015-02-24 Method for assessment of azilsartan efficacy in treatment of patients with ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of the ventricle according to "hypertrophic" type

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201501599U UA100785U (en) 2015-02-24 2015-02-24 Method for assessment of azilsartan efficacy in treatment of patients with ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of the ventricle according to "hypertrophic" type

Publications (1)

Publication Number Publication Date
UA100785U true UA100785U (en) 2015-08-10

Family

ID=54771872

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201501599U UA100785U (en) 2015-02-24 2015-02-24 Method for assessment of azilsartan efficacy in treatment of patients with ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of the ventricle according to "hypertrophic" type

Country Status (1)

Country Link
UA (1) UA100785U (en)

Similar Documents

Publication Publication Date Title
UA100785U (en) Method for assessment of azilsartan efficacy in treatment of patients with ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of the ventricle according to "hypertrophic" type
UA100786U (en) Method for assessment of irbesartan efficacy in treatment of patients with ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to "hypertrophic" type
UA101654U (en) Method for assessment of olmesartan efficacy in treatment of patients with ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
UA91678U (en) Method for assessment of pitavastatin efficacy in treatment of patients with ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to "hypertrophic" type
UA91262U (en) Method for assessment of fenofibrate efficacy in treatment of patients with ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to "hypertrophic" type
UA86077U (en) Method for assessing efficacy of inosine in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
UA86076U (en) Method for assessing efficacy of meldonium phosphate in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
UA59416U (en) Method for assessment of treatment efficacy in patients with ischemic heart disease with angina pectoris and arterial hypertension with hypertrophic type impairment of diastolic function of left ventricle
UA81783U (en) Method for assessing efficacy of azelnidipin in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
UA71694U (en) Method for assessing efficacy of lovastatin in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
UA80784U (en) Method for assessing efficacy of barnidipin in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
UA71709U (en) Method for assessing efficacy of simvastatin in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
UA55362U (en) Method for assessing efficacy of felodipine in treatment of ischemic heart disease with angina pectoris and arterial hypertension with hypertrophic type of impairment of diastolic function of left ventricle
UA56814U (en) Method for assessing efficacy of nisoldipine for treatment of ischemic heart disease with angina pectoris and arterial hypertension with hypertrophic-type impairment of diastolic function of left ventricle
UA71695U (en) Method for assessing efficacy of ivabradin in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
UA54819U (en) Method for assessing efficacy of cilasapril treatment in patients with ischemic heart disease, angina and arterial hypertension with impaired diastolic function of left ventricle of 'hypertrophic' type
UA55363U (en) Method for assessing efficacy of amlodipin in treatment of ischemic heart disease with angina pectoris and arterial hypertension with hypertrophic type of impairment of diastolic function of left ventricle
UA71706U (en) Method for assessing efficacy of isosorbid mononitrate in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
UA64627U (en) Method for assessing efficacy of oxprenolol treatment in patients with ischemic heart disease, cardiac angina and arterial hypertension with impaired diastolic function of left ventricle of 'hypertrophic' type
UA61995U (en) method for evaluating the effectiveness of treatment of patients with ischemic heart disease with angina pectoris and arterial hypertension with diastolic dysfunction of the left ventricle by "hypertrophic" type
UA64628U (en) Method for assessing efficacy of celiprolol treatment in patients with ischemic heart disease, cardiac angina and arterial hypertension with impaired diastolic function of left ventricle of 'hypertrophic' type
UA62810U (en) Method for assessing efficacy of treating patients with ischemic heart disease and angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
UA81645U (en) Method for assessing efficacy of efonidipin in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
UA71708U (en) Method for assessing efficacy of pravastatin in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
UA62007U (en) method for evaluating the effectiveness of treatment with trimetazidine of patients with ischemic heart disease with angina pectoris and arterial hypertension with diastolic dysfunction of the left ventricle of "hypertrophic" type